SCP Partners

SCP Partners

Signal active

Investment Firm

Overview

SCP Partners is a principal investment firm specializing in early stage companies with exceptional technology or other proprietary advantages that are poised to capitalize on major market trends; expansion stage companies that are largely past product or technology development risk and can demonstrate some level of actual market validation; and later stage, middle market, and buyout opportunities that are attractively priced and offer upside growth potential through strategy modification and management rejuvenation. The firm seeks to invest in information and communications technology which includes network hardware and software, wireless communications, distributed computing and interoperable web-based services, rich media creation and distribution infrastructure, and Internet infrastructure; life sciences which includes medical devices for therapeutic uses, novel diagnostics and imaging, specialty pharmaceuticals, and drug delivery; services including financial services, health care services, information technology services, and medical services; and defense and security which includes surveillance and monitoring, flexible, rapid deployment communications technologies for military and emergency situations, software for operationally intensive environments, and data archiving, search, and retrieval. It primarily invests in the United States and can also consider a limited number of investments in foreign countries.

Highlights

Founded

1996

Industry

Financial Services

Employees

11-50

Investment

32

Lead Investment

15

Exits

10

Stages

Early Stage Venture, Late Stage Venture

Investor Type

Venture Capital

Location

United States, North America

Contact Information

Social

Profile Resume

SCP Partners, established in 1996 and headquartered in United States, North America., specializes in Early Stage Venture, Late Stage Venture investments across Internet, Education, EdTech, Venture Capital, Advertising, Hardware, Software, Video Streaming, Developer Tools, Ad Targeting. The organization boasts a portfolio of 32 investments, with an average round size of $17.7M and 10 successful exits. Their recent investments include Apreso Classroom, Court Square Ventures, Anystream, FourthWall Media, Sevin Rosen Funds. The highest investment round they participated in was $20.6B. Among their most notable exits are Apreso Classroom and Court Square Ventures. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.

Employees

imagePlace Winston J. Churchill

Winston J. Churchill

Managing General Partner

imagePlace Roger Carolin

Roger Carolin

Venture Partner

imagePlace Thomas G. Rebar

Thomas G. Rebar

Partner

imagePlace Richard L. Sherman

Richard L. Sherman

Venture Partner

imagePlace John Keane

John Keane

Venture Partner

imagePlace Charles C. Freyer

Charles C. Freyer

Chief Administrative Officer

Investment portfolio

SCP Partners has made 32 investments. Their most recent investment was on Dec 24, 2019, when Oncology Pharma raised $38.4M.

SCP Partners has made 5 diversity investments. Their most recent diversity investment was on Aug 03, 2006, when FourthWall Media raised $20.0M.

investments

32

Diversity investments

5

Lead investments

15

Number of exits

10

Investments

32

Annouced DateOrganization NameIndustryMoney Raised
Oct 30, 2008
Echo360 Echo360
Information Technology46.5M
Apr 07, 2010
Echo360 Echo360
Information Technology26.4M
Jul 08, 2013
Magnolia Broadband Magnolia Broadband
Semiconductor3.0M
Dec 24, 2019
Oncology Pharma Oncology Pharma
Medical38.4M

Exits

10

Funding Timeline

Funding rounds

32

Investors

0

Funds

2

Funding Rounds

32

SCP Partners has raised 32 rounds. Their latest funding was raised on Dec 24, 2019 from a Post-IPO Debt - Oncology Pharma round.

Annouced DateTransaction NameNumber of InvestorsMoney RaisedLead Investor
Oct 30, 2008
Venture Round - Echo360 Venture Round - Echo360
-46.5M-
Apr 07, 2010
Venture Round - Echo360 Venture Round - Echo360
-26.4M-
Jul 08, 2013
Venture Round - Magnolia Broadband Venture Round - Magnolia Broadband
-3.0M-
Dec 24, 2019
Post-IPO Debt - Oncology Pharma Post-IPO Debt - Oncology Pharma
-38.4M-

Investors

0

There is no funding round available on this profile

Fund raised

2

Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.

Annouced DateFund NameMoney Raised
May 10, 2013
fund image OTPPLESS
1.0M
May 11, 2013
fund image OTPPLESS
1.0M

Invest in industries

Recent Activity

There is no recent news or activity for this profile.